Home » News » India » 'Let's Face it, Can't Fulfil Goal': Delhi HC's Reality Check for India's Dec 31 Vaccination Target
1-MIN READ

'Let's Face it, Can't Fulfil Goal': Delhi HC's Reality Check for India's Dec 31 Vaccination Target

The Delhi HC  made the observations during the hearing of a petition filed by advocate Rakesh Malhotra, in which it has been monitoring the Covid-19 situation in Delhi.

The Delhi HC made the observations during the hearing of a petition filed by advocate Rakesh Malhotra, in which it has been monitoring the Covid-19 situation in Delhi.

The court made the observations during the hearing of a petition filed by advocate Rakesh Malhotra, in which it has been monitoring the Covid-19 situation in Delhi.

The Delhi High Court has pointed out the slow pace of the ongoing Covid-19 inoculation drive and said that the target set to vaccinate the entire adult population by December 31 was unlikely to be met.

“God knows whether we will achieve our target of December 31 that we have set. Looks like we are not. Just yesterday, it was in the press that we need to vaccinate 90 lakh people a day to be able to achieve that. How will we achieve that? We don’t have that kind of infrastructure. We don’t have that kind of vaccination. So obviously we are not going to meet it. Let’s face it,” said the Division Bench of Justices Vipin Sanghi and Jasmeet Singh.

The court made the observations during the hearing of a petition filed by advocate Rakesh Malhotra, in which it has been monitoring the Covid-19 situation in Delhi.

On June 4, the court had asked the Ministry of Corporate Affairs to consider expanding the definition of Corporate Social Responsibility (CSR) activities to enable a vaccine-producing company to provide free vaccines, or a company running a hospital to provide free treatment for Covid-19 as part of CSR. At present, CSR rules exclude “activities undertaken in pursuance of the normal course of business of the company”.

RELATED NEWS

Meanwhile, the Centre told the court that the company law committee has not recommended such a move. However, amid pandemic such an exemption has been provided to allow CSR in normal business for research and development of new vaccines. An Indian Express report stated that such research and development is allowed in collaboration with certain specific organisations.

Senior Advocate Rajshekhar Rao, amicus curiae, told the court that this exemption did not answer the issue highlighted by the court. Meanwhile, the court added that the purpose of the exemption seemed to be to ensure funds for some government research organisations. “These are all your babies,” it said.

It added that the government needs to move with the time and it was for a specific purpose – Covid-19, if there are hospitals or pharmaceutical companies which are doling out medicines, giving free treatment… that should be part of CSR, said the Division Bench.

The Centre said there was no prohibition in offering Covid-related services as CSR, provided it was not the normal course of business of the company.

Read all the Latest News, Breaking News and Coronavirus News here

first published:August 05, 2021, 09:30 IST